Loading

Slzii.com Search

Search (News)

Ribo Announces Phase 2 Clinical Trial Submission To EMA, Further Advancing Sirna Therapeutics In Thromboembolic Disease

Ribo Announces Phase 2 Clinical Trial Submission To EMA, Further Advancing Sirna Therapeutics In Thromboembolic Disease
english top health

(MENAFN - PR Newswire) SUZHOU, China and MO–LNDAL, Sweden, May 28, 2026 /PRNewswire/ -- Suzhou Ribo Life Science (stock code 06938) and Ribocure Pharmaceuticals (together "Ribo") announce the ...
2026-05-27 23:01:20

What are you doing?
0.10478401184082


News
News

Latest News and Headlines
(MENAFN - PR Newswire) SUZHOU, China and MO–LNDAL, Sweden, May 28, 2026 /PRNewswire/ -- Suzhou Ribo Life Science (stock code 06938) and Ribo...
News